AcelRx Pharmaceuticals, Inc. to Discuss Phase 3 Top-line Results Involving the Sufentanil NanoTab PCA System - Conference Call

AcelRx Pharmaceuticals, Inc. to Discuss Phase 3 Top-line Results Involving the Sufentanil NanoTab PCA System - Conference Call

Nov 15, 2012 from 8:00 AM to 8:00 AM EST

Live Teleconference Information

Primary # -
Secondary # -

Canada - 866-605-3852